Cargando…

Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib

BACKGROUND: Tyrosine kinase inhibitors (TKI) have enriched the therapeutic options in patients with renal cell carcinoma (RCC), which frequently induce morphological changes in tumors. However, only little is known about the biological activity of TKI. Circulating endothelial cells (CEC) have been a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruenwald, Viktor, Beutel, Gernot, Schuch-Jantsch, Susanne, Reuter, Christoph, Ivanyi, Philipp, Ganser, Arnold, Haubitz, Marion
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023793/ https://www.ncbi.nlm.nih.gov/pubmed/21194438 http://dx.doi.org/10.1186/1471-2407-10-695

Ejemplares similares

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
por: Eggers, Hendrik, et al.
Publicado: (2022)

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
por: Kappler, Paula, et al.
Publicado: (2021)

CT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational study
por: Dettmer, Sabine, et al.
Publicado: (2017)

Pre T-Cell Receptor Alpha (pTα) Expression Patterns and Functional Analysis in Human T-Cell Lymphoblastic Leukemia
por: Ivanyi, Philipp, et al.
Publicado: (2010)

Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas
por: Paule, Bernard, et al.
Publicado: (2010)

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
por: Möhn, Nora, et al.
Publicado: (2019)

Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application
por: Ukena, Sya N., et al.
Publicado: (2012)

Impact of sarcopenia in advanced and metastatic soft tissue sarcoma
por: Strassmann, Dennis, et al.
Publicado: (2021)

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells
por: HUANG, LIMIN, et al.
Publicado: (2015)

Drug resistance-related sunitinib sequestration in autophagolysosomes of endothelial cells
por: Wu, Shuang, et al.
Publicado: (2019)

Identification of novel regulators in T-cell differentiation of aplastic anemia patients
por: Franzke, Anke, et al.
Publicado: (2006)

Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib
por: Fiorio Pla, Alessandra, et al.
Publicado: (2014)

Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation
por: Brossa, Alessia, et al.
Publicado: (2015)

Effect of cAMP derivates on assembly and maintenance of tight junctions in human umbilical vein endothelial cells
por: Beese, Michaela, et al.
Publicado: (2010)

Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells
por: Norton, Kerri-Ann, et al.
Publicado: (2014)

Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence
por: Wang, Denian, et al.
Publicado: (2020)

The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma
por: Nagaya, Naoya, et al.
Publicado: (2018)

Circulating endothelial cells (CECs) and E-selectin: Predictors of preeclampsia
por: Mehrabian, Ferdous, et al.
Publicado: (2012)

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study
por: Tullemans, Bibian M. E., et al.
Publicado: (2022)

Circulating Endothelial Progenitor Cells in Kidney Transplant Patients
por: Di Marco, Giovana S., et al.
Publicado: (2011)

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis
por: Eggers, Hendrik, et al.
Publicado: (2017)

Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells
por: Brossa, Alessia, et al.
Publicado: (2018)

Effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular risk indices in renal cell carcinoma
por: Lai, Silvia, et al.
Publicado: (2020)

A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma
por: Ivanyi, Philipp, et al.
Publicado: (2023)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Sunitinib for advanced renal cell cancer
por: Coppin, Chris
Publicado: (2008)

Sunitinib resistance in renal cell carcinoma
por: Morais, Christudas
Publicado: (2014)

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
por: Ivanyi, Philipp, et al.
Publicado: (2023)

Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy
por: Möhn, Nora, et al.
Publicado: (2020)

Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib
por: Huang, Limin, et al.
Publicado: (2014)

Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance
por: Kirsch, Torsten, et al.
Publicado: (2010)

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis
por: Zhu, Hao‐Hua, et al.
Publicado: (2021)

Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2019)

Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer
por: Rossi, E, et al.
Publicado: (2012)

(18)F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
por: Derlin, Thorsten, et al.
Publicado: (2020)

Circulating endothelial progenitor cells
por: Garmy-Susini, B, et al.
Publicado: (2005)

Endothelial EphrinB2 Regulates Sunitinib Therapy Response in Murine Glioma
por: Broggini, Thomas, et al.
Publicado: (2022)

Circulating endothelial progenitor cells and endothelial cells in moyamoya disease
por: Bao, Xiang‐Yang, et al.
Publicado: (2018)

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
por: Czarnecka, Anna M., et al.
Publicado: (2019)

Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cells
por: Weissinger, Eva M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lb996kf3qdunevs58dfnittkal